WINNIPEG, Aug. 7, 2017 /CNW/ - Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, today reported its results from operations for the quarter ended June 30, 2017.
Quarter Ended June 30, 2017 Highlights:
Recorded net revenue of $20.3 million during the quarter ended June 30, 2017 compared to $7.7 million for the quarter ended June 30, 2016, an increase of 164%;
